Haemonetics Fair Value
HA
The fair market value of HAZ.MU stock is 104.25 EUR. Relative to the market price of 0 EUR Haemonetics is undervalued by 28.2%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Haemonetics Valuation
The fair value level of 104.25 EUR can be considered as an effective entry point for long-term investors to start investing in HAZ.MU stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
HAZ.MU stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Haemonetics Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
74.55
2
Median P/E over 5 years
45.2
3
Minimum P/E over 5 years
34.86
4
Earning per share (last 12 months)
2.43 USD
Maximum value
1
x
4
=
171.95 EUR
Fair value
2
x
4
=
104.25 EUR
Minimum value
3
x
4
=
80.41 EUR
Haemonetics Corp price metrics
-5.62
Annual return (geometric mean)
44.67
Risk (standard deviation) of returns
β
1.46
Beta (volatility compared to market)